Search For "msn laboratories"
MSN Laboratories Launches Affordable JAK Inhibitors to Boost Access for In
Updated : 5 months, 2 weeks ago IST
New Delhi [India], October 9: MSN Laboratories, a leading global Indian pharmaceutical company, today announced that it is the first to launch the revolutionary JAK inhibitor molecules Tofacitinib (Tofadoz) and Upadacitinib (Upadoz) in India.
Read More
Anurag University Signs MoU with MSN Laboratories
Updated : 5 months, 3 weeks ago IST
Hyderabad (Telangana) [India], September 17: Anurag University has further strengthened its industry partnerships by signing a Memorandum of Understanding (MoU) with MSN Laboratories Limited, one of India's leading pharmaceutical companies. The collaboration also marks the announcement of a
Read More
MSN Laboratories Earns Great Place to Work® Certification: A Celebrat
Updated : 1 year, 7 months ago IST
Hyderabad (Telangana) [India], July 30: MSN Laboratories is delighted to announce its recognition as a Great Place to Work® by the esteemed Great Place to Work® Institute. This prestigious certification highlights the dedication, passion, and commitment of MSN's incredible team, wh
Read More
Understanding treatment and management of Kidney Cancer
Updated : 3 years, 11 months ago IST
New Delhi [India] April 13 (ANI/Mediawire): Kidneys are nature's most sophisticated filters. They are bean-shaped organs that filter whole blood by extracting many elements and retaining the required elements for the whole body. They filter urine and unnecessary waste products and maintai
Read More
MSN Laboratories enters into licence agreement with DRDO for 2 DG
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], July 9 (ANI): MSN Laboratories Pvt. Ltd. (MSN) on Friday announced that it has entered into a licence agreement with the Defence Research and Development Organisation (DRDO) for the manufacturing, distribution and marketing of COVID-19 2- Deoxy-D-Glucose (2-DG)
Read More
COVID-19: MSN Laboratories initiates Phase III clinical trial of Molnupira
Updated : 4 years, 10 months ago IST
New Delhi [India], May 26 (ANI): MSN Laboratories Private Limited (MSN) is initiating phase III clinical trial of Molnupiravir capsules for the treatment of COVID-19 in India.
Read More
Lilly signs 3 more pacts to accelerate availability of baricitinib for Cov
Updated : 4 years, 10 months ago IST
New Delhi [India], May 13 (ANI): Eli Lilly and Company said on Thursday it has issued additional royalty-free, non-exclusive voluntary licenses to Dr Reddy's Ltd, MSN Laboratories and Torrent Pharmaceuticals who will collaborate to accelerate and expand the availability of baricitinib in Ind
Read More